Jan‐Shiang Taur

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Joe Bentz, Michael O′Connor, Dallas Bednarczyk et al. · Drug Metabolism and Disposition · 2013 · 147 citations · Full text

Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions

Harma Ellens, Shibing Deng, JoAnn Coleman et al. · Drug Metabolism and Disposition · 2013 · 42 citations · Full text

Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models

Jan‐Shiang Taur, Rosita Rodriguez‐Proteau · Xenobiotica · 2008 · 36 citations

Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells

Jan‐Shiang Taur, Christopher DesJardins, Edgar Schuck et al. · Xenobiotica · 2010 · 23 citations